Ms. Cheryl Janus

Ms. Cheryl Janus serves as a MMESO West Clinical Analyst, providing critical clinical and operational expertise to support the acquisition of surgical appliances and medical supplies within the Department of Defense’s medical logistics framework. In this role, she acts as a subject matter expert who bridges clinical requirements with procurement strategy, ensuring that acquired products meet rigorous safety, efficacy, and interoperability standards. Her work directly informs solicitation development, technical evaluations, and contract execution for high-acuity care environments, making her a key contributor to the readiness and sustainability of military medical supply chains. While no contractor relationships are currently documented in the system, Ms. Janus collaborates with a diverse range of manufacturers and distributors specializing in sterile surgical kits, implantable devices, and single-use medical consumables. Her procurement approach emphasizes technical compliance, supply chain resilience, and adherence to federal medical device regulations, fostering partnerships with vendors capable of meeting Defense Logistics Agency (DLA) and Joint Medical Command standards. Ms. Janus’s contracting portfolio reflects a 100% preference for non-set-aside acquisitions, indicating a focus on commercial-off-the-shelf (COTS) medical products that meet standardized military specifications without socioeconomic constraints. This pattern suggests a prioritization of mission-critical availability, regulatory compliance, and supply chain continuity over socioeconomic set-asides, though she remains compliant with all federal small business participation requirements. Her primary NAICS focus—339113, Surgical Appliance and Supplies Manufacturing—reflects deep expertise in procuring Class II and Class III medical devices, including orthopedic implants, surgical drapes, and sterile instrument trays. She specializes in evaluating product certifications, FDA clearances, and ISO 13485 compliance, ensuring that all acquisitions align with DoD clinical protocols and global supply chain security standards.